The Discounted Cash Flow (DCF) valuation of Cytokinetics Inc (CYTK) is (152.81) USD. With the latest stock price at 38.89 USD, the upside of Cytokinetics Inc based on DCF is -492.9%.
Based on the latest price of 38.89 USD and our DCF valuation, Cytokinetics Inc (CYTK) is a sell. selling CYTK stocks now will result in a potential gain of 492.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 10.2% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (521.51) - (93.25) | (152.81) |
| Upside | -1441.0% - -339.8% | -492.9% |